PubMedopen access
A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer.
humans, carcinoma, non-small-cell lung, female, lung neoplasms, cancer vaccines, nivolumab
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 646483
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.